Alpine Global Management’s Mural Oncology MURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-161,928
Closed -$521K 209
2024
Q4
$521K Sell
161,928
-48,660
-23% -$172K 0.07% 139
2024
Q3
$659K Sell
210,588
-90,387
-30% -$294K 0.16% 96
2024
Q2
$945K Buy
300,975
+201,116
+201% +$741K 0.16% 112
2024
Q1
$488K Buy
+99,859
New +$485K 0.09% 121

Other funds holding MURA

Alpine Global Management's MURA Position: Q1 2025 in Review

Alpine Global Management sold out of Mural Oncology (MURA) in Q1 2025, closing a stake of 161,928 shares — an estimated $521K sold.

Alpine Global Management first reported a position in MURA in Q1 2024 and held it in 4 quarters. The position peaked at $945K in Q2 2024. 68 funds tracked by Wall St. Rank hold MURA as of Q1 2025.

  • Alpine Global Management reported no remaining Mural Oncology position as of Q1 2025 after selling out during the quarter.
  • Alpine Global Management sold 161,928 Mural Oncology shares in Q1 2025, an estimated $521K.
  • Alpine Global Management first reported a position in Mural Oncology in Q1 2024 and held it in 4 quarters.
  • Alpine Global Management's Mural Oncology position peaked at $945K in Q2 2024.
  • 68 funds tracked by Wall St. Rank held Mural Oncology as of Q1 2025.

Based on Alpine Global Management's 13F filing for Q1 2025, filed 15 May 2025.